![Max Jonson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Max Jonson
Direttore Finanziario/CFO presso BURE EQUITY AB
Patrimonio netto: 526 017 $ in data 30/06/2024
Profilo
Max Jonson is currently a Director at BioLamina AB, Bure Growth AB, Skanditek AB, Bure Equity AB, and Bure Equity (Private Equity).
He previously worked as a Director at Celemiab Group AB, Dipylon Medical AB, Atle Investment Management AB, Celemi International AB, SEB Group (Sweden), Orasolv AB, Dpnova AB, Stockholm School of Economics Ifl, ACQ Bure AB, Sse Executive Education, and Yubico AB.
Mr. Jonson holds an MBA from The University of Chicago and an undergraduate degree from New York University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
BURE EQUITY AB
0.02% | 28/05/2024 | 15 604 ( 0.02% ) | 526 017 $ | 30/06/2024 |
Posizioni attive di Max Jonson
Società | Posizione | Inizio |
---|---|---|
BURE EQUITY AB | Direttore Finanziario/CFO | 01/10/2013 |
Skanditek AB | Direttore/Membro del Consiglio | - |
BioLamina AB
![]() BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Direttore/Membro del Consiglio | - |
Bure Growth AB
![]() Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | Direttore/Membro del Consiglio | - |
Bure Equity (Private Equity)
![]() Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Direttore Finanziario/CFO | 01/09/2013 |
Precedenti posizioni note di Max Jonson
Società | Posizione | Fine |
---|---|---|
Celemi International AB | Direttore/Membro del Consiglio | 01/01/2018 |
Dipylon Medical AB
![]() Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Direttore/Membro del Consiglio | 01/01/2017 |
Celemiab Group AB
![]() Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Celemiab Group AB provides consultancy and training services. The firm offers organizational learning. It helps businesses improves corporate merger, product launch, and new corporate strategy results through business simulations and training solutions. The company was founded by Klas Mellander, Eva Brita Margareta Barchan, and Krister Nathanaelson in 1985 and is headquartered in Malmo, Sweden. | Direttore/Membro del Consiglio | 01/01/2016 |
Sse Executive Education | Direttore Finanziario/CFO | 01/01/2013 |
░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Max Jonson
The University of Chicago | Masters Business Admin |
New York University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BURE EQUITY AB | Finance |
YUBICO AB | Distribution Services |
Aziende private | 13 |
---|---|
Dpnova AB
![]() Dpnova AB Medical/Nursing ServicesHealth Services DPNOVA, headquartered in Malmö, is the leading dental laboratory in Sweden with over 207 MSEK in revenue over 250 employees across five locations (Malmö, Stockholm, Göteborg, Sjöbo, and Jönköping). Started in 1950, DPNOVA delivers a full range of dental lab services to dentists. | Health Services |
ACQ Bure AB
![]() ACQ Bure AB Financial ConglomeratesFinance ACQ Bure AB is a non-operational acquisition company. Its investment strategy is to identify and complete an acquisition of a company that can create value for the shareholders over time. The company was founded on October 26, 2020 and is headquartered in Stockholm, Sweden. | Finance |
Bure Equity (Private Equity)
![]() Bure Equity (Private Equity) Investment ManagersFinance Bure Equity AB Private Equity (BEPE) is the private equity investment division of the Swedish firm, Bure Equity AB (ST: BURE). In 1992, the firm was founded as Bure Förvaltnings AB. In 2000, the firm changed their name to Bure Equity AB and decided to focus entirely on private equity investments. BEPE specializes in long-term ownership of unlisted firms. They operate from offices in Stockholm, Sweden. | Finance |
Atle Investment Management AB | |
Bure Growth AB
![]() Bure Growth AB Financial ConglomeratesFinance Bure Growth AB invests in development companies. The firm was founded in 2014 and is headquartered in Stockholm, Sweden. | Finance |
BioLamina AB
![]() BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
Celemi International AB | |
Celemiab Group AB
![]() Celemiab Group AB Miscellaneous Commercial ServicesCommercial Services Celemiab Group AB provides consultancy and training services. The firm offers organizational learning. It helps businesses improves corporate merger, product launch, and new corporate strategy results through business simulations and training solutions. The company was founded by Klas Mellander, Eva Brita Margareta Barchan, and Krister Nathanaelson in 1985 and is headquartered in Malmo, Sweden. | Commercial Services |
Orasolv AB
![]() Orasolv AB Medical/Nursing ServicesHealth Services Orasolv AB engages in the provision of dental care. It acquires, develops, and manages practices within the dental sector, as well as delivers consultancy services to Swedish dentists. The firm also operates a chain of dental clinics. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Health Services |
SEB Group (Sweden) | |
Skanditek AB | |
Dipylon Medical AB
![]() Dipylon Medical AB Pharmaceuticals: MajorHealth Technology Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden. | Health Technology |
Sse Executive Education |
- Borsa valori
- Insiders
- Max Jonson